Moody's Investors Service said Tuesday the medical products and device sector is set for stable growth, though it may not fully recover to pre-recession levels.
"We foresee generally stable business fundamentals for the medical products and device sector over the next 12 months to 18 months," said Diana Lee, a Moody's senior credit officer.
The growth drivers and negative effects of the economy will vary by sub-sector, Moody's said. Hospital supply companies should be among the most resilient. Also, Moody's doesn't expect a significant decline in the growth of hospital admissions over the near-term, even though the extension of COBRA health benefits to the jobless is winding down.
New product launches should benefit medical device companies, along with a gradual recovery in equipment spending by hospitals, Moody's said.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement